SciELO - Scientific Electronic Library Online

vol.74 número1Lipoperoxidación de membranas y daño ultraestructural por estrés oxidativo en isquemia-reperfusión miocárdicaUtilidad de la derivación aVR en la identificación de la arteria responsable en el infarto inferior índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Revista argentina de cardiología

versión On-line ISSN 1850-3748


ROLANDI, Florencia et al. NT-proBNP Predicts Clinical Outcomes in Patients with NSTE- ACS and Preserved Left Ventricular Function. Rev. argent. cardiol. [online]. 2006, vol.74, n.1, pp. 19-27. ISSN 1850-3748.

Background NT-proBNP levels are associated with left ventricular (LV) dysfunction and adverse outcome in non-ST-elevation acute coronary syndromes (NSTE-ACS). There is little evidence about the prognostic information of NT-proBNP in patients with normal LV function and NSTE-ACS. Work Objective To assess the prognostic value of NT-proBNP in patients with NSTE-ACS and without systolic dysfunction. Research Design and Methods From a cohort of patients with NSTE-ACS who underwent in-hospital angiography, we selected 393 who showed a left ventricular ejection fraction ≥40%. Independent core labs analyzed angiograms and NT-proBNP, troponin T, myoglobin and C-reactive protein measurements. Analyses were performed using a cut-off point of NT-proBNP of 586 pg/ml. The primary endpoint was incidence of death or myocardial infarction (MI) at 180 days. Results Eighty-three patients (21%) had NT-proBNP levels ≥586 pg/ ml, and 310 (79%) had NT-proBNP levels <586 pg/ml. Patients with increased NT-proBNP were older and more often females; they showed a higher proportion of elevated serum markers and a higher proportion of extended coronary disease and complex coronary lesions. Compared with those with NT-proBNP <586 pg/ml, these patients showed higher incidence of death (9.6% vs. 2.3%; p = 0.002), myocardial infarction (9.6% vs. 3.2%; p = 0.01), and death or MI (16.9% vs. 5.5%; p = 0.001) at 180 days. In a multivariate analysis including clinical, ECG and angiographic features, NT-proBNP was an independent predictor of total death and death /MI at 6 months. Conclusions NT-proBNP is an independent predictor of death or myocardial infarction and total death at 6 months in patients with NSTE-ACS and without systolic dysfunction.

Palabras clave : Natriuretic peptides; Myocardial ischemia; Prognosis.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License